Search research articles
Contact Us
Filters
Showing results (391-400 of 395) with videos related to
Page
of 40
Sort By:
You have reached the last page of results.
This site can display upto 395 results.
Science Translational Medicine
|
June 23, 2021
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2018
Artemisinin resistance phenotypes and K13 inheritance in a <i>Plasmodium falciparum</i> cross and <i>Aotus</i> model
Juliana M Sá, Sarah R Kaslow, Michael A Krause, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Cancer Immunology, Immunotherapy : CII
|
September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
Francesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Page
of 40
Search research articles
Search
Showing results (391-400 of 395) with videos related to
Sort By:
Page
of 40
You have reached the last page of results.
This site can display upto 395 results.
Science Translational Medicine
|
June 23, 2021
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2018
Artemisinin resistance phenotypes and K13 inheritance in a <i>Plasmodium falciparum</i> cross and <i>Aotus</i> model
Juliana M Sá, Sarah R Kaslow, Michael A Krause, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Cancer Immunology, Immunotherapy : CII
|
September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII
|
April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study
Francesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Page
of 40